When every market prices the US: the new logic of launch sequencing

For most of the last two decades, the order in which a company entered global markets was an operational question. Which market had the fastest regulatory pathway, the readiest payer, the strongest local partner. Price was set market by market, and the low prices a company accepted in smaller economies largely stayed there.

That world is closing. As Most-Favored-Nation pricing arrives in the United States and international reference pricing tightens across regions, the price a company accepts in one market increasingly follows it into others, including the largest market in the world. Launch sequencing has become a pricing decision.

Markets are no longer independent

Ex-US markets have moved from being downstream recipients of pricing strategy to being active inputs into US benchmarking risk. A net price accepted in a smaller market, once contained, can now cascade into US benchmarks and rebate exposure. The value of a market is no longer just its own revenue. It is its own revenue minus the reference-pricing cost it imposes everywhere the reference net reaches.

That changes three things at once. Market attractiveness has to be modelled as a system, because a market that looks appealing on local volume can turn unattractive once its price becomes visible to a larger one. Timing carries pricing risk, because launching early in a low-price market can lock in a reference point before the higher-value price is set. And the pressure to delay or skip markets grows, falling hardest on those least able to absorb it.

What teams are doing about it

The teams navigating this well are not freezing. They are adapting the tools of the trade: confidential net-price contracting that keeps low prices out of public reference baskets, second-brand and differentiated approaches, and sequencing strategies designed to protect global price corridors without abandoning lower-income markets.

The discipline this requires

Most organisations are not built for this. Regulatory, pricing, and market access functions still run market by market, with the interdependencies living in spreadsheets and institutional memory rather than in the decision itself. Policy has changed faster than the processes built for the old world.

Closing that gap starts with three habits. Build the reference-price map before committing to a launch, not after. Model sequences, not just markets. And treat every access negotiation in a small market as what it now is: a decision with consequences far beyond that market's borders.

The question that now precedes every entry decision is no longer only whether you can get approved here. It is what the price you accept here costs you everywhere else.